Difficulty: Medium
Average Score: 80%
Practice
Which of the following medications that treat Alzheimer's disease causes slowing of the heart rate and fainting episodes?
Correct answer
D
Rationale
In this question, the correct answer is D) All of the above. Tacrine (Cognex), Galantamine (Razadyne), and Donepezil (Aricept) are all medications used to treat Alzheimer's disease. These medications are cholinesterase inhibitors, which work by increasing the levels of acetylcholine in the brain to help improve cognitive function in individuals with Alzheimer's disease.
Among the side effects of cholinesterase inhibitors, bradycardia (slowing of the heart rate) and syncope (fainting episodes) are known adverse effects. This is due to the medications' effects on the cholinergic system, which can lead to systemic effects including bradycardia.
Option A) Tacrine (Cognex), Option B) Galantamine (Razadyne), and Option C) Donepezil (Aricept) are incorrect because they are all associated with causing bradycardia and fainting episodes as potential side effects in patients taking these medications for Alzheimer's disease.
In an educational context, it is crucial for healthcare providers to be aware of the potential side effects of psychotropic medications used in the treatment of Alzheimer's disease. Understanding the side effect profiles of these medications can help healthcare professionals monitor patients effectively, manage side effects, and provide comprehensive care for individuals with Alzheimer's disease.
Among the side effects of cholinesterase inhibitors, bradycardia (slowing of the heart rate) and syncope (fainting episodes) are known adverse effects. This is due to the medications' effects on the cholinergic system, which can lead to systemic effects including bradycardia.
Option A) Tacrine (Cognex), Option B) Galantamine (Razadyne), and Option C) Donepezil (Aricept) are incorrect because they are all associated with causing bradycardia and fainting episodes as potential side effects in patients taking these medications for Alzheimer's disease.
In an educational context, it is crucial for healthcare providers to be aware of the potential side effects of psychotropic medications used in the treatment of Alzheimer's disease. Understanding the side effect profiles of these medications can help healthcare professionals monitor patients effectively, manage side effects, and provide comprehensive care for individuals with Alzheimer's disease.